Leonard Schleifer
Fortuna: 1 505 M $ al 30/06/2026
Fortuna: 1 505 M $ al 30/06/2026
Fundador de Regeneron Pharmaceuticals, Inc., Leonard S. Schleifer es copresidente, consejero delegado y director de esta empresa. Anteriormente fue profesor adjunto en el Weill Cornell Medical College. El Dr. Schleifer se doctoró en la Universidad de Virginia.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 14/04/2026 | 1.725.565 ( 82,56 % ) | 1 076 M $ | 30/06/2026 | |
| 14/04/2026 | 688.088 ( 0,67 % ) | 429 M $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| REGENERON PHARMACEUTICALS, INC. | Director Ejecutivo | 08/01/1988 |
Regeneron Ireland DAC
Regeneron Ireland DAC BiotechnologyHealth Technology Operates as a biotechnology company which develops medicines for serious diseases | Director Ejecutivo | 01/01/2013 |
| Empresas | Cargo | Fin |
|---|---|---|
Weill Cornell Medical College
Weill Cornell Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops, manufactures and commercializes medicines for diseases | Health Technology |
University of Virginia
University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Weill Cornell Medical College
Weill Cornell Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Regeneron Ireland DAC
Regeneron Ireland DAC BiotechnologyHealth Technology Operates as a biotechnology company which develops medicines for serious diseases | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.